Kairos Pharma, LTD. Contracts & Agreements

70 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Placement Agent Agreement, dated January 16, 2025, between Kairos Pharma, Ltd. and Boustead Securities LLC
Kairos Pharma, LTD.
2025
Form of Common Warrants
Kairos Pharma, LTD.
2025
Form of Placement Agent Warrants
Kairos Pharma, LTD.
2025
Form of Amended and Restated Securities Purchase Agreement
Purchase Agreements
Kairos Pharma, LTD.
2025
Form of Pre-Funded Warrant
Warrant Agreements
Kairos Pharma, LTD.
2025
Form of Common Warrant
Warrant Agreements
Kairos Pharma, LTD.
2025
Form of Securities Purchase Agreement
Purchase Agreements
Kairos Pharma, LTD.
2025
Form of Registration Rights Agreement
Registration Rights Agreements
Kairos Pharma, LTD.
2025
Form of Lock-up Agreement
Kairos Pharma, LTD.
2025
Director Offer Letter, dated December 10, 2024, between Kairos Pharma, Ltd. and Rahul Singhvi
Kairos Pharma, LTD.
2024
Purchase Agreement, dated November 12, 2024, by and between Kairos Pharma, Ltd. and Helena Global Investment Opportunities I Ltd
Purchase Agreements
Kairos Pharma, LTD.
2024
Second Conversion Agreement, dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center
Kairos Pharma, LTD.
2024
Third Amendment to Exclusive License Agreement (Cancer Autoimmune), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center
License Agreements
Kairos Pharma, LTD.
2024
Fourth Amendment to Exclusive License Agreement (Depletion of DNA), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center and Enviro...
License Agreements
Kairos Pharma, LTD.
2024
Third Amendment to Exclusive License Agreement (Fibrosis), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center
License Agreements
Kairos Pharma, LTD.
2024
Third Amendment to Exclusive License Agreement (RelA of NF-kB), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center
License Agreements
Kairos Pharma, LTD.
2024
Fourth Amendment to Exclusive License Agreement (Sensitization of Solid Tumors), dated November 13, 2024, by and between Enviro Therapeutics Inc. and Cedars-Sinai Medical Center
License Agreements
Kairos Pharma, LTD.
2024
Form of the Amendment No.1 to the Employment Agreement by and between Kairos Pharma, Ltd and Doug Samuelson
Employment Agreements
Kairos Pharma, LTD.
2024
Form of the Amendment No.1 to the Employment Agreement by and between Kairos Pharma, Ltd and Dr. Ramachandran Murali
Employment Agreements
Kairos Pharma, LTD.
2024
Form of the Amendment No.1 to the Employment Agreement by and between Kairos Pharma, Ltd and Dr. Neil Bhowmick
Employment Agreements
Kairos Pharma, LTD.
2024
Form of Amendment No. 1 to Employment Agreement by and between Kairos Pharma, Ltd. and John S. Yu
Employment Agreements
Kairos Pharma, LTD.
2024
Consulting Agreement, dated October 1, 2024, between Kairos Pharma, Ltd., Cross Current Capital LLC and Alan Masley
Consulting Agreements
Kairos Pharma, LTD.
2024
Form of Advertising Services Agreement, dated September 23, 2024, between the Company and CEO.CA Technologies, Inc
Services Agreements
Kairos Pharma, LTD.
2024
Form of Advisory & Consulting Agreement, dated September 23, 2024, between the Company and Belair Capital Advisors Inc
Consulting Agreements
Kairos Pharma, LTD.
2024
Bioassay Services Agreement between the Company and PreCheck, dated September 20, 2024
Services Agreements
Kairos Pharma, LTD.
2024
Underwriting Agreement between Kairos Pharma, Ltd. and Boustead Securities, LLC dated September 16, 2024
Underwriting Agreements
Kairos Pharma, LTD.
2024
Common Stock Purchase Warrant issued to Boustead Securities, LLC, dated September 17, 2024
Warrant Agreements
Kairos Pharma, LTD.
2024
Common Stock Purchase Warrant issued to EF Hutton LLC, dated September 17, 2024
Warrant Agreements
Kairos Pharma, LTD.
2024
Master Services Agreement, dated August 1, 2024, between Kairos Pharma Limited and Prevail InfoWorks, Inc
Services Agreements
Kairos Pharma, LTD.
2024
Amendment to Loan Agreement, dated August 16, 2024, between the Company and John S. Yu
Loan Agreements
Kairos Pharma, LTD.
2024
Amendment to Loan Agreement, dated August 16, 2024, between the Company and Doug Samuelson
Loan Agreements
Kairos Pharma, LTD.
2024
Amendment to Laon Agreement, dated August 16, 2024, between the Company and Neil Bhowmick
Kairos Pharma, LTD.
2024
Form of Underwriting Agreement by and between Kairos Pharma, Ltd. and Boustead Securities, LLC, as representative of the underwriters
Underwriting Agreements
Kairos Pharma, LTD.
2024
Form of Representatives Warrant
Warrant Agreements
Kairos Pharma, LTD.
2024
Conversion Agreement, dated March 7, 2024, between Cedars-Sinai Medical Center, Kairos Pharma, Ltd. and Enviro Therapeutics, Inc
Kairos Pharma, LTD.
2024
Second Amendment to the Exclusive License Agreement to Methods and Use of Compounds that Bind to RelA of NF-kB, dated March 7, 2024, between Kairos Pharma Ltd. and Cedars-Sinai...
License Agreements
Kairos Pharma, LTD.
2024
Second Amendment to the Exclusive License Agreement to Composition and Methods for Treating Fibrosis with Kairos Pharma Ltd, dated March 7, 2024, between Kairos Pharma, Ltd. and...
License Agreements
Kairos Pharma, LTD.
2024
Second Amendment to the Exclusive License Agreement to Compositions and Methods for Treating Cancer and Autoimmune Diseases, dated March 7, 2024, between Kairos Pharma, Ltd. and...
License Agreements
Kairos Pharma, LTD.
2024
Third Amendment to Exclusive License to Compositions and Methods for Treating Diseases and Conditions by Depletion of Mitochondrial or Genomic DNA, dated March 7, 2024, between...
License Agreements
Kairos Pharma, LTD.
2024
Third Amendment to the Exclusive License Agreement to Sensitization of Tumors to Therapies Through Endoglin Antoganism, dated March 7, 2024, between Enviro Therapeutics, Inc. and...
License Agreements
Kairos Pharma, LTD.
2024
Form of Loan Agreement, dated April 26, 2024, between the Company and Certain Officers
Loan Agreements
Kairos Pharma, LTD.
2024
Agreement of Merger between Kairos Pharma, Ltd. and AcTcell Biopharma, Inc. dated November 13, 2019
Merger Agreements
Kairos Pharma, LTD.
2023
Share Exchange Agreement between Kairos Pharma, Ltd. and Enviro Therapeutics, Inc. dated June 3, 2021
Exchange Agreements
Kairos Pharma, LTD.
2023
Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated March 16, 2020 (re Depletion of Mitochondrial DNA)
Kairos Pharma, LTD.
2023
Amendment to Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated January 11, 2021 (re Depletion of Mitochondrial DNA)
Kairos Pharma, LTD.
2023
Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated March 16, 2020 (re Sensitization of Solid Tumors)
Kairos Pharma, LTD.
2023
Amendment to Exclusive Option Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated January 9, 2021 (re Sensitization of Solid Tumors)
Kairos Pharma, LTD.
2023
Exclusive License Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated June 21, 2021 (re Compositions and Methods for Treating Diseases and Conditions...
License Agreements
Kairos Pharma, LTD.
2023
Exclusive License Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated June 2, 2021 (re Sensitization of Tumors to Therapies Through Endoglin...
License Agreements
Kairos Pharma, LTD.
2023
Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. (as successor to AcTcell Biopharma, Inc.) dated August 30, 2019 (re Methods of generating...
License Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated June 17, 2021 (re Methods of generating activated T cells for cancer...
License Agreements
Kairos Pharma, LTD.
2023
Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated October 1, 2017 (re Methods of use of compounds that bind to RelA of NFkB)
License Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated June 17, 2021 (re Methods of use of compounds that bind to RelA of NFkB)
License Agreements
Kairos Pharma, LTD.
2023
Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated October 1, 2017 (re Composition and Methods for Treating Fibrosis)
License Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated June 17, 2021 (re Composition and Methods for Treating Fibrosis)
License Agreements
Kairos Pharma, LTD.
2023
Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated March 12, 2019 (re Composition and Methods for Treating Cancer and Autoimmune...
License Agreements
Kairos Pharma, LTD.
2023
Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Kairos Pharma, Ltd. dated June 17, 2021 (re Composition and Methods for Treating Cancer and...
License Agreements
Kairos Pharma, LTD.
2023
License and Supply Agreement between Tracon Pharmaceuticals, Inc., Enviro Therapeutics, Inc., and Kairos Pharma, Ltd. dated May 21, 2021
License Agreements
Kairos Pharma, LTD.
2023
First Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated April 18, 2022
License Agreements
Kairos Pharma, LTD.
2023
Second Amendment to Exclusive License Agreement between Cedars-Sinai Medical Center and Enviro Therapeutics, Inc. dated October 11, 2022
License Agreements
Kairos Pharma, LTD.
2023
Form of Subscription Agreement for 6% Convertible Notes
Note Agreements
Kairos Pharma, LTD.
2023
Form of 6% Convertible Note
Note Agreements
Kairos Pharma, LTD.
2023
Form of Investor Rights and Lock-Up Agreement for 6% Convertible Notes
Note Agreements
Kairos Pharma, LTD.
2023
Kairos Pharma, Ltd. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Kairos Pharma, LTD.
2023
Form of Director Offer Letter
Kairos Pharma, LTD.
2023
Form of Employment Agreement for John Yu
Employment Agreements
Kairos Pharma, LTD.
2023
Form of Employment Agreement with Doug Samuelson
Employment Agreements
Kairos Pharma, LTD.
2023
Form of Employment Agreement for Neil Bhowmick
Employment Agreements
Kairos Pharma, LTD.
2023
Form of Employment Agreement for Ramachandran Murali
Employment Agreements
Kairos Pharma, LTD.
2023
Form of Indemnification Agreement between Kairos Pharma, Ltd. and each of its directors
Indemnification Agreements
Kairos Pharma, LTD.
2023